IOBT Research and Charts

IOBT - IO Biotech Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 0.37	Change ⇓ 0.00 (0.00%)	Volume 2,634,933
	Open 0.37	High 0.39	Low 0.34

8EMA (Daily) 0.34	40EMA (Daily) 0.49	50EMA (Daily) 0.53	STO (Daily) 33.405	MACD Hist (Daily) 0.024
8EMA (Weekly) 0.466	40EMA (Weekly) 0.92	50EMA (Weekly) 0.98	STO (Weekly) 12.623	MACD Hist (Weekly) -0.008


Company Profile
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.